Showing results (81-90 of 138) with videos related to

Sort By:
Pageof 14
Gastroenterology|October 1, 1989
Ornithine decarboxylase and diamine oxidase in human colon carcinoma cell line CaCo-2 in cultureL D'Agostino, B Daniele, S Pignata, et al.
Journal of the National Cancer Institute|July 22, 1998
Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotideF Ciardiello, R Caputo, R Bianco, et al.
Tumori|August 31, 1993
Chemotherapy with mitomycin C and vinblastine in pretreated metastatic breast cancerF Perrone, S De Placido, C Carlomagno, et al.
Anti-Cancer Drugs|April 1, 1995
Bryostatin 1 enhances lymphokine activated killer sensitivity and modulates the beta 1 integrin profile of cultured human tumor cellsP Correale, M Caraglia, A Fabbrocini, et al.
British Journal of Cancer|October 1, 1990
Prolactin receptor does not correlate with oestrogen and progesterone receptors in primary breast cancer and lacks prognostic significance. Ten year results of the Naples adjuvant (GUN) studyS De Placido, C Gallo, F Perrone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2000
Antitumor activity of combined treatment of human cancer cells with ionizing radiation and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotideC Bianco, R Bianco, G Tortora, et al.
International Journal of Cancer|August 22, 1995
Microsatellite instability and pathological aspects of breast cancerA Contegiacomo, R Palmirotta, L De Marchis, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|May 1, 1993
Thyroid-stimulating hormone-regulated growth and cell cycle distribution of thyroid cells involve type I isozyme of cyclic AMP-dependent protein kinaseG Tortora, S Pepe, A M Cirafici, et al.
American Journal of Clinical Oncology|June 1, 1994
Mitomycin C and mitoxantrone in anthracycline-pretreated advanced breast cancer patients. A phase II studyF Perrone, S De Placido, C Carlomagno, et al.
Cancer Research|September 15, 1991
Reversal of adriamycin resistance by recombinant alpha-interferon in multidrug-resistant human colon carcinoma LoVo-doxorubicin cellsS Scala, R Pacelli, R V Iaffaioli, et al.
Pageof 14